Kepler Capital Markets Analysts Give Sanofi (EPA:SAN) a €88.00 Price Target

Share on StockTwits

Kepler Capital Markets set a €88.00 ($102.33) price objective on Sanofi (EPA:SAN) in a report issued on Friday, Borsen Zeitung reports. The firm currently has a buy rating on the stock.

A number of other research analysts have also issued reports on the stock. Goldman Sachs Group set a €81.00 ($94.19) price target on shares of Sanofi and gave the company a neutral rating in a research note on Monday, August 5th. Credit Suisse Group set a €82.00 ($95.35) price target on shares of Sanofi and gave the company a buy rating in a research note on Tuesday, July 30th. UBS Group set a €87.00 ($101.16) price target on shares of Sanofi and gave the company a buy rating in a research note on Wednesday, August 14th. Deutsche Bank set a €92.00 ($106.98) price target on shares of Sanofi and gave the company a buy rating in a research note on Monday, September 2nd. Finally, Oddo Bhf set a €94.00 ($109.30) price target on shares of Sanofi and gave the company a buy rating in a research note on Tuesday, July 30th. Five investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. The company presently has a consensus rating of Buy and an average price target of €87.27 ($101.47).

Shares of Sanofi stock opened at €79.53 ($92.48) on Friday. Sanofi has a 12-month low of €63.09 ($73.36) and a 12-month high of €92.97 ($108.10). The company’s 50 day moving average is €76.18.

About Sanofi

Sanofi provides therapeutic solutions. It offers Cerezyme and Cerdelga for Gaucher disease, Myozyme and Lumizyme for Pompe disease, Fabrazyme for Fabry disease, and Aldurazyme for mucopolysaccharidosis Type 1; Aubagio, an immunomodulatory; and Lemtrada, a monoclonal antibody to treat multiple sclerosis.

Featured Story: How to invest in blue-chip stocks

Analyst Recommendations for Sanofi (EPA:SAN)

Receive News & Ratings for Sanofi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Gantzert Investment Co. LLC ADV Buys 1,935 Shares of IBM
Gantzert Investment Co. LLC ADV Buys 1,935 Shares of IBM
iShares Edge MSCI Min Vol USA ETF  is Epstein & White Financial LLC’s 5th Largest Position
iShares Edge MSCI Min Vol USA ETF is Epstein & White Financial LLC’s 5th Largest Position
Gantzert Investment Co. LLC ADV Acquires 9,490 Shares of General Mills, Inc.
Gantzert Investment Co. LLC ADV Acquires 9,490 Shares of General Mills, Inc.
Procter & Gamble Co  Shares Bought by Gantzert Investment Co. LLC ADV
Procter & Gamble Co Shares Bought by Gantzert Investment Co. LLC ADV
Michael Patrick O’Shea Acquires 50,000 Shares of Premier Asset Management Group PLC  Stock
Michael Patrick O’Shea Acquires 50,000 Shares of Premier Asset Management Group PLC Stock
JetBlue Airways Co.  CEO Sells $41,550.00 in Stock
JetBlue Airways Co. CEO Sells $41,550.00 in Stock


© 2006-2019 Ticker Report